An Unbiased Mass Spectrometry Approach Identifies Glypican-3 as an Interactor of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and Low Density Lipoprotein Receptor (LDLR) in Hepatocellular Carcinoma CellsKévin Ly, Robert Day|Journal of Biological Chemistry|2016Cited by 17
Enhanced anti-tumor activity of the Multi-Leu peptide PACE4 inhibitor transformed into an albumin-bound tumor-targeting prodrugAnna Kwiatkowska, Robert Day|Scientific Reports|2019Cited by 11